Related Articles
CISPLATIN PLUS VP16 AS SALVAGE TREATMENT FOR ADVANCED BREAST-CARCINOMA RESISTANT OR RECURRENT AFTER 1ST LINE CHEMOTHERAPY FOR METASTATIC DISEASE
Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB
Rapid and early α‑fetoprotein and des‑γ‑carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma
Drug resistance analysis of gefitinib-targeted therapy in non-small cell lung cancer